B. Wojciak-Stothard

This study identifies ARF6 as a novel activator of HIF-2alpha in pulmonary arterial hypertension and shows that the antibiotic CTC inhibits this pathway.

This study shows that endothelial miR-150 protects against pulmonary arterial hypertension by regulating PTPMT1 and cardiolipin synthesis, reducing inflammation and apoptosis.

This study identifies KLF2-induced microRNAs that protect endothelial cells and reduce pulmonary hypertension in animal models and patient samples.